Local delivery of an antithrombin inhibits platelet-dependent thrombosis

43Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Background: Platelet-dependent thrombosis can be effectively inhibited by intravenous administration of direct thrombin antagonists. However, an increased propensity for abnormal bleeding has been associated with systemic administration of these agents. The goal of this study was to determine whether local delivery of a potent thrombin inhibitor, D-Phe-L-Pro-L-Arg chloromethyl ketone (PPACK), could inhibit platelet-dependent thrombosis without altering systemic hemostatic function. Methods and Results: Thrombus formation was measured by quantitative imaging of 111In-labeled platelet deposition on segments of thrombogenic vascular graft interposed in arteriovenous shunts in a porcine model. Intravenous administration of PPACK inhibited platelet deposition at a dose of 12.5 μg/kg per minute, which was associated with significant prolongations of both template bleeding times and activated partial thromboplastin times. By contrast, local infusion of PPACK at a dose of 0.02 μg/kg per minute (ie, a 600-fold smaller dose) into the fluid boundary layer at the interface between flowing blood and the thrombogenic segment produced equivalent inhibition of platelet deposition without prolonging either the bleeding time or the activated partial thromboplastin time. In addition, static exposure of a mural thrombus to solutions of PPACK at concentrations ≥2.5 mg/mL for 15 minutes produced sustained inhibition of platelet-dependent thrombosis with no change in hemostatic measurements. Conclusions: These results indicate that local delivery of the direct antithrombin PPACK, by either boundary layer infusion or static application techniques, effectively inhibits platelet-dependent thrombosis at doses that are several orders of magnitude less than the systemic dose required for an equivalent antithrombotic effect. In contrast to the systemic administration of PPACK, local delivery produced maximal inhibition of thrombosis without alterations in hemostasis.

Author supplied keywords

References Powered by Scopus

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

2890Citations
N/AReaders
Get full text

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1135Citations
N/AReaders
Get full text

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

979Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Irreversible inhibitors of serine, cysteine, and threonine proteases

984Citations
N/AReaders
Get full text

Antiplatelet Drugs: A Comparative Review

230Citations
N/AReaders
Get full text

Synthetic inhibitors of thrombin and factor Xa: From bench to bedside

165Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Scott, N. A., Nunes, G. L., King, S. B., Harker, L. A., & Hanson, S. R. (1994). Local delivery of an antithrombin inhibits platelet-dependent thrombosis. Circulation, 90(4 I), 1951–1955. https://doi.org/10.1161/01.CIR.90.4.1951

Readers over time

‘10‘13‘16‘17‘18‘20‘2500.751.52.253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

70%

Professor / Associate Prof. 2

20%

Researcher 1

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

44%

Agricultural and Biological Sciences 2

22%

Biochemistry, Genetics and Molecular Bi... 2

22%

Chemistry 1

11%

Save time finding and organizing research with Mendeley

Sign up for free
0